Joe Shmmoe
MEMBERS ONLY
Added to Favorites
Favorite removed
Want to read more? Create a FREE account on aarp.org.
A healthy lifestyle helps protect the brain. Make brain health a habit and register on aarp.org to access Staying Sharp.
Login to Unlock AccessNot Registered? Create Account
Add to My Favorites
Added to My Favorites
Completed
by Candy Sagon
Updated September 28, 2022
Could the drug you take regularly for insomnia, depression, allergies, bladder problems or even the common cold put you at greater risk for mental decline, or even dementia?
For the past decade, a growing number of studies have raised red flags about a common class of medications — called anticholinergics — that are frequently used by older adults.
These drugs, available both over the counter and by prescription, are used for a range of disorders, from hay fever and sleep problems to overactive bladder and Parkinson’s disease.
There’s a long list of medications included in the anticholinergic group — one estimate put it at 600 drugs — but some of the most common are old-school antihistamines like Benadryl (diphenhydramine); sleep aid drugs like Nytol, Advil PM and Tylenol PM, which all contain diphenhydramine; certain antidepressants like Paxil (paroxetine) and Elavil (amitriptyline); and overactive bladder medications like oxybutynin (brand names include Ditropan XL and Oxytrol).
How these drugs may affect your mind and health
Studies show that regularly taking more than one anticholinergic drug, or taking even the minimum effective dose of one anticholinergic for longer than three years, is linked to a higher likelihood of dementia in older adults.
Anticholinergic drugs work by blocking a natural chemical in the brain, called acetylcholine, which helps different types of cells communicate with each other. It’s important for heart rate and certain muscle contractions, and it’s also vital for memory and learning.
According to these studies, that’s why taking these drugs may interfere with thinking ability, a side effect that doctors thought was reversible once a person stopped taking the medication but that subsequent research suggests can last for many years. In addition, the drugs may have a greater effect in those already at risk for Alzheimer’s.
What worries Shelly Gray, an anticholinergics researcher and director of the Plein Center for Geriatric Pharmacy Research, Education and Outreach at the University of Washington, is that many older adults — an estimated 1 in 3 — take anticholinergic medications, including over-the-counter ones like cold and allergy drugs and sleep aids, and may not be aware of the long-term effects on their brain health.
They also may not even realize they’re taking multiple anticholinergic drugs — both prescription and nonprescription — “which is why it’s important to tell your health care provider about all drugs you take, including the over-the-counter ones, and ask if there are safer alternatives,” she stressed in an interview.
Here’s how the research about the worrisome effects of these drugs stacks up:
Researchers from the University of California, San Diego, followed 688 cognitively normal older adults, average age 74, who were taking at least one anticholinergic drug. Many were taking more than four. The participants were given annual mental skills tests for up to 10 years and the scientists looked at whether they had biomarkers — such as certain types of proteins in their spinal fluid — or genetic risk factors for Alzheimer’s disease.
Researchers found that those at greater risk for Alzheimer’s were 47 percent more likely to develop mild cognitive impairment, often a precursor to dementia, compared to those who did not take these drugs.
What you should know:
Gray, a professor in the School of Pharmacy at the University of Washington who specializes in medication safety for older adults, had these suggestions for avoiding anticholinergics, if possible:
• “Cumulative Use of Strong Anticholinergic Medications and Incident Dementia,” JAMA Internal Medicine, March 2015. Read the full study.
• “Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study,” JAMA Internal Medicine, June 2019. This study evaluated two years of data from 58,769 patients with dementia and 225,574 controls age 55 years or older. Read the full study.
• “Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II,” BMC Geriatrics, July 2020. Read the full study.
• “Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults,” Neurology, October 2020. This study evaluated 10 years of data from 688 participants from the Alzheimer’s Disease Neuroimaging Initiative. Read a summary of the study. (A fee is required to access the full study.)
Create the Good
Find nearby volunteer opportunities that interest you
AARP Medicare Resource Center
Helpful resources to manage your current Medicare situation